Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
Official title: Effects of a Pulmonary and Cardiovascular Rehabilitation Program
Run by University of Campinas, Brazil · NCT06772922 · Data updated 2026-11-12
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | University of Campinas, Brazil Academic / other |
| Locations | 1 site (Campinas, São Paulo) |
| Status | Recruiting |
| Started | March 3, 2019 |
| Main results expected | November 3, 2024 |
| Study ends | December 20, 2025 |
| Registry record updated | January 14, 2025 |
| Trial ID | NCT06772922 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with COPD, pulmonary emphysema, pulmonary fibrosis, asthma, or various cardiovascular conditions such as myocardial infarction and chronic heart failure.
✕Probably not a fit
Patients with contraindications to exercise, such as significant arrhythmias or untreated heart disease, may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effects of a pulmonary and cardiovascular rehabilitation program on patients with chronic respiratory diseases and cardiovascular conditions. It aims to improve functional capacity, quality of life, and respiratory variables over a 3-month period. Participants will engage in exercise interventions tailored to their specific health needs, focusing on those diagnosed with conditions like COPD, asthma, and heart diseases. The program is conducted at the physical therapy service of CECOM at the University of Campinas.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life and functional capacity for patients with chronic respiratory and cardiovascular conditions.
How similar studies have gone: Previous studies have shown that pulmonary and cardiovascular rehabilitation programs can effectively improve patient outcomes, indicating a strong potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Candidates for the pulmonary rehabilitation program: users diagnosed with chronic obstructive pulmonary disease (COPD), pulmonary emphysema, pulmonary fibrosis, asthma or other lung disease. * Candidates for the cardiovascular rehabilitation program: users diagnosed with acute myocardial infarction, myocardial revascularization surgery, coronary angioplasty, stable angina, valve replacement, chronic heart failure and who meet the criteria for phase III of cardiovascular rehabilitation. * Referral with medical clearance for rehabilitation Exclusion Criteria: * Patients with any contraindication to aerobic or muscle-strengthening physical exercise, such as significant arrhythmias, untreated heart disease, myocarditis, recent or untreated pulmonary embolism, and uncontrolled systemic arterial hypertension, among other conditions.
Where it's running
-
Unicamp
Campinas, São Paulo, Brazil Recruiting
Study contacts
- Study coordinator: Letícia Baltieri
- Email: lbaltieri@yahoo.com.br
- Phone: +55(19)35218936
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea
In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.
-
See if video telemedicine with a caller’s mobile camera improves care for adults with acute dyspnea
This study tests whether adding video calls from a caller’s mobile phone to the emergency dispatch process helps improve care for adults with acute shortness of breath.
-
CardioStory device in helping tell heart failure from other causes in people with shortness of breath
This study tests whether the CardioStory noninvasive device can help emergency department clinicians distinguish heart failure from other causes of dyspnea in adults.
-
Normal lung and heart function references for healthy US veterans who served in Southwest Asia
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.